Cargando…
Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and overall survival
OBJECTIVE: Neoadjuvant chemotherapy (NACT) represents a treatment option in patients with advanced epithelial ovarian cancer (AEOC) who are not good candidates for primary debulking surgery. Usually, 3 cycles of chemotherapy before surgery have been considered the best option for patient survival, a...
Autores principales: | Coada, Camelia Alexandra, Dondi, Giulia, Ravegnini, Gloria, Di Costanzo, Stella, Tesei, Marco, Fiuzzi, Enrico, Di Stanislao, Marco, Giunchi, Susanna, Zamagni, Claudio, Bovicelli, Alessandro, Hrelia, Patrizia, Angelini, Sabrina, De Iaco, Pierandrea, Perrone, Anna Myriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627748/ https://www.ncbi.nlm.nih.gov/pubmed/37743060 http://dx.doi.org/10.3802/jgo.2023.34.e82 |
Ejemplares similares
-
Classification Systems of Endometrial Cancer: A Comparative Study about Old and New
por: Coada, Camelia Alexandra, et al.
Publicado: (2021) -
Role of Circulating miRNAs in Therapeutic Response in Epithelial Ovarian Cancer: A Systematic Revision
por: Ravegnini, Gloria, et al.
Publicado: (2021) -
Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma
por: Perrone, Anna Myriam, et al.
Publicado: (2023) -
Emerging Role of MicroRNAs in the Therapeutic Response in Cervical Cancer: A Systematic Review
por: Ravegnini, Gloria, et al.
Publicado: (2022) -
Identification of miR-499a-5p as a Potential Novel Biomarker for Risk Stratification in Endometrial Cancer
por: Ravegnini, Gloria, et al.
Publicado: (2021)